ELV Operating Margin
3.51%TTM
Period ending:
ELV FY Operating Margin%
10.86%-1.16%
1998-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
ELV operating margin history
Operating income as a percentage of revenue. The available annual fiscal periods series contains 28 observations from Dec 31, 1998 to Dec 31, 2025.
| Period ending | Operating Margin |
|---|---|
| 4.0738% | |
| 5.0269% | |
| 5.1039% | |
| 5.3967% | |
| 6.4527% | |
| 6.3274% | |
| 6.4608% | |
| 6.3373% | |
| 5.5367% | |
| 6.377% | |
| 6.7619% | |
| 6.8976% | |
| 6.5902% | |
| 7.1632% | |
| 7.3704% | |
| 8.214% | |
| 8.0179% | |
| 7.9422% | |
| 9.6992% | |
| 9.4073% | |
| 9.1511% | |
| 8.6184% | |
| 7.1577% | |
| 6.1147% | |
| 5.0226% | |
| 0% | |
| 0% | |
| 0% |
Compare operating margin
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) operating margin
- Johnson & Johnson (JNJ) operating margin
- AbbVie (ABBV) operating margin
- UnitedHealth Group (UNH) operating margin
- Merck & Co. (MRK) operating margin
- Thermo Fisher Scientific (TMO) operating margin
- Amgen (AMGN) operating margin
- Gilead Sciences (GILD) operating margin
Compare all covered stocks by operating margin →
All ELV financial metrics · ELV stock overview · How to interpret financial metrics
